Samsung Medical Center announced on July 1 that Professor Heecheol Park from the Department of Radiation Oncology has been inaugurated as the 28th President of the Korean Liver Cancer Association. His term will last for one year, until June 2027.


Heechul Park, President of the Korean Liver Cancer Association

Heechul Park, President of the Korean Liver Cancer Association

View original image

The newly appointed President Park graduated from Yonsei University College of Medicine in 1992 and has been serving as a professor in the Department of Radiation Oncology at Samsung Medical Center since 2005. He is currently the Director of the Proton Therapy Center. His main clinical and research interests include radiosurgery and proton therapy, which are non-surgical local treatments for liver cancer. He is dedicated to expanding the application of curative proton radiosurgery for patients with liver cancer who are difficult to treat with standard therapies and developing 'personalized ultra-hypofractionated adaptive radiotherapy (PULSAR)' techniques combining immunotherapy and radiotherapy, thereby striving to improve patients' quality of life.


In 2024, Samsung Medical Center became the first single hospital in Korea to achieve 2,000 cases of proton therapy for liver cancer, with Park contributing significantly to this achievement. He is currently leading research in the next-generation field of proton therapy known as 'FLASH' radiotherapy.


The Korean Liver Cancer Association was established in 1999 as the Liver Cancer Study Group and has spent nearly 30 years focusing on multidisciplinary research and advocating for optimal care for liver cancer. Additionally, the association designated February 2 as 'Liver Cancer Day' to promote public awareness of early diagnosis. This date emphasizes the importance of high-risk groups aged 40 and older undergoing two types of tests (liver ultrasound and blood tests) twice a year for early detection.


President Park plans to focus on strengthening the association's global standing and moving closer to the public during his term. He aims to bring the International Liver Cancer Association (ILCA) School of Liver Cancer professional education program to Korea in 2027 and to support the successful hosting of the Asia-Pacific Primary Liver Cancer Expert Meeting 2027, scheduled for July 2027.


Furthermore, considering the shift in major causes of liver cancer—while the number of chronic viral hepatitis patients is decreasing, cases of metabolic dysfunction-associated fatty liver disease are increasing—he plans to actively utilize the association's website and social media to enhance communication with the public.



President Park stated, "If we prepare well for today by leveraging rapidly evolving technologies such as artificial intelligence (AI), I believe we can welcome a fundamentally different and better tomorrow. Just as experts from various fields have created synergy and set an example as a multidisciplinary association, I will work together with everyone to build a new future for our association."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing